Immediate Impact
10 standout
Citing Papers
Recent progress of CDK4/6 inhibitors’ current practice in breast cancer
2024 Standout
Aging and cancer
2024 Standout
Works of Miriam O’Connor being referenced
Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial
2023
Comparing attitudes of younger and older patients towards cancer clinical trials
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Miriam O’Connor | 42 | 36 | 21 | 23 | 18 | 106 | |
| Richa Shah | 49 | 24 | 26 | 10 | 21 | 162 | |
| Ahmad Deeb | 32 | 26 | 19 | 7 | 20 | 130 | |
| F. Di Salvo | 61 | 62 | 12 | 15 | 16 | 147 | |
| Emmanuelle Jacquet | 41 | 13 | 26 | 17 | 12 | 75 | |
| Jayeshkumar Patel | 47 | 15 | 17 | 6 | 21 | 206 | |
| Jeroen W. G. Derksen | 96 | 19 | 16 | 7 | 21 | 171 | |
| Mathias Warm | 86 | 71 | 27 | 25 | 20 | 177 | |
| Stephen Della‐Fiorentina | 114 | 36 | 37 | 19 | 24 | 178 | |
| A. H. Partridge | 114 | 34 | 23 | 10 | 17 | 153 | |
| Arnaud Bayle | 49 | 66 | 63 | 11 | 24 | 150 |
All Works
Loading papers...